Skip to main content

Featured

Daily Markets Update: TSX Rebounds, Europe Hits a Record, Nvidia Shock Rattles Asia (Nov. 12)

  CANADIAN MONEY BRIEF · DAILY MARKETS UPDATE Thursday, November 12, 2026 · Covers Wednesday’s close and Thursday’s Asian session Markets got their AI swagger back on Wednesday — and then Nvidia took some of it away overnight. A strong CoreWeave report lifted tech, pushed the S&P/TSX Composite higher and sent Europe to a record close, but reports that Nvidia’s board is weighing whether to remove CEO Jensen Huang rattled Asian chip stocks on Thursday and pointed U.S. futures lower. AT A GLANCE TSX: +0.67% to 36,411.72, recovering part of Tuesday’s hot-inflation drop. Wall Street: S&P 500 +1.31%, Nasdaq +1.60%, Dow +0.49% as CoreWeave revived the AI trade. Europe: STOXX 600 and Germany’s DAX both closed at records. Asia (Thursday): Taiex -2.63%, Nikkei -0.70% on Nvidia leadership worries. Gold slipped under US$4,000 on a firmer U.S. dollar; oil rebounded from two-month lows. Canada: TSX Claws Back Tuesday’s Loss The S&P/TSX Composite rose 241.27 points, or 0.67%, to...

article

Provincial Directive Curbs AHS Authority Over Private Surgical Contract Negotiations

 


In a significant policy shift, Alberta Health Minister Adriana LaGrange has stripped Alberta Health Services (AHS) of its authority to negotiate contracts with private surgical facilities. According to a government directive obtained by media, the change came after internal concerns—raised by the agency’s then-chief executive—over rising contract costs.

Documents, including a letter from former AHS CEO Athana Mentzelopoulos’s lawyer, allege that senior government officials—even involving Premier Danielle Smith’s former chief of staff—intervened in AHS’s procurement process to favor private companies. This interference reportedly undermined AHS’s established negotiation powers and raised serious questions about transparency in the province’s health system. 

A separate report in a Morning Update from Unpublished Newswire reiterated the move, noting that the directive is part of broader reforms aimed at reducing costs by leveraging competitive pricing in surgical services.  Meanwhile, a CityNews investigation has added context to the controversy, citing denials by private surgical providers who label the allegations of sweetheart deals as “false and baseless.” 

Critics and opposition leaders are calling for further inquiry into the decision-making process behind these changes, arguing that the shift could signal a move toward greater privatization of public health services. In contrast, government representatives insist that the directive is intended solely to improve efficiency and ensure more competitive pricing for publicly funded operations.

Comments